Colgate-palmolive Co

Institutional 13F data shows net value increase of $4.087 billion in the latest quarter, with 890 net buyers versus 814 net sellers. Insider activity over 90 days shows only 8 sells totaling $25.1 million, with zero insider buying.

Confirmation

Continued institutional net buying in the next quarter would confirm the bullish momentum.

Invalidation Risk

A shift to institutional net selling or a surge in insider sales would negate this outlook.

The above is AI-generated from public regulatory filings and summarizes historical data only. It is not investment advice and should not be used as the basis for any buy or sell decision.

Insider Trading (Form 4)

90d confidence

unique buyers

—

buy value

data as of 2026-07-17

12-Month Buy/Sell Activity

Feb 25

Feb 26

BuySell

操作	內部人	職稱	交易日	金額
賣出	Tsourapas Panagiotis	COO, Eur., APac, Afr Eur, Skin	2026-02-12	$1.47M
賣出	Tsourapas Panagiotis	COO, Eur., APac, Afr Eur, Skin	2026-02-11	$3.31M
賣出	Hazlin John	Chief Growth Officer	2026-02-10	$1.98M
賣出	Malcolm Gregory	EVP and Controller	2026-02-06	$1.21M
賣出	Massey Sally	Chief Human Resources Officer	2026-02-05	$1.51M
賣出	SUTULA STANLEY J III	Chief Financial Officer	2026-02-04	$9.22M
賣出	Jennifer Daniels	CLO and Secretary	2026-02-04	$2.08M
賣出	Wallace Noel R.	Chairman, President & CEO	2026-02-04	$4.28M

View all insider trades →

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding COLGATE-PALMOLIVE CO (CL)?

Major stakeholders currently include BlackRock, Inc. ($6.2B), Vanguard Capital Management LLC ($4.5B), State Street CORP ($4.1B). Based on the latest 13F filings, there are a total of 1949 tracked investment funds and institutions maintaining positions in CL.

What is the overall institutional sentiment toward CL recently?

Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $4.1B, driven by 890 managers accumulating shares while 814 reduced their exposure.

Which institutions have been selling or reducing their CL positions?

In the latest period, 707 funds trimmed their holdings, and 107 managers completely exited their positions. The aggregate reported sell value was $20.8B.

Are there any notable investors adding CL to their portfolios?

Yes, buying activity remains notable. 175 institutions opened new positions in {ticker}, and 715 existing holders added to their shares. The total reported buy value for the quarter amounted to $33.1B.